Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

House Ways and Means Committee Chairman Richard Neal (D-Mass.), Speaker of the House Nancy Pelosi (D-Calif.), and Senate Minority Leader Charles Schumer (D-N.Y.) talk to reporters at the White House April 30, 2019 in Washington, D.C.

House Ways and Means Committee Chairman Richard Neal (D-Mass.), Speaker of the House Nancy Pelosi (D-Calif.), and Senate Minority Leader Charles Schumer (D-N.Y.) talk to reporters at the White House April 30, 2019 in Washington, D.C. (Photo: Chip Somodevilla/Getty Images)

Schumer Revealed as Key Industry Ally in Defeat of Effort to Curb Surprise Billing

It was one of a series of lobbying victories by the healthcare industry in 2019 bolstered by top Democrats.

Eoin Higgins

Senate Minority Leader Chuck Schumer worked behind the scenes through December in the Senate to defeat a bipartisan initiative to curb suprise medical billing, according to a new report Friday which details the lobbying victories won by the for-profit healthcare industry in 2019.

"The success shows how formidable the health-care industry remains."

Reporting Friday by the Washington Post's Jeff Stein and Yasmeen Abutaleb points to Schumer, a New York Democrat, as a consequential figure in stopping the surprise billing measure from being included in an end-of-year spending bill.

As Common Dreams reported on Tuesday, Rep. Richard Neal (D-Mass.), chairman of the House Ways and Means Committee, effectively killed the bill last week by introducing a competing measure and pushing off the legislation until 2020. 

According to the Post

On Dec. 6, two days before a bipartisan group of lawmakers announced an agreement to their efforts, Schumer called a key player in the negotiations—Sen. Patty Murray (D-Wash.), the top-ranking Democrat on the Senate health committee—to express his disapproval of the measure, which negotiators had been crafting since the spring, according to three people familiar with the conversation who spoke on the condition of anonymity to discuss private talks.

Several people close to the negotiations said it was widely believed that Schumer was acting on behalf of powerful New York hospital groups, who have donated at least $1 million this year to the Senate Democratic fundraising arm. 

In a statement to the Post, Schumer's team denied that donations had anything to do with the senator's intercession in the process and that the New York Democrat was not affected in the decision-making process by political donations.

Congress plans to look into the practice of surprise billing after the holiday, reported Politico:

Committee leaders are requesting information from eight companies about the billing policies and practices of insurers and physician staffing companies previously accused of sending surprise bills.

In comment to Politico reporter Rachel Roubein, Greater NY Hospital Association (GNYHA) president Kenneth Raske said the surprise billing legislation which failed included "needless provisions that benefit for-profit insurers while severely harming hospitals and physicians."

"This rush to get surprise billing language into an end-of-year funding bill, without regard to real-world consequences to health care providers, is dangerous and unnecessary," said Raske. "Congress should slow down to ensure that this important issue is done thoughtfully and carefully."

GNYHA opposition to the legislation was noted in a piece in The Hill last month.

According to Open Secrets, GNYHA has given Schumer's Senate Majority PAC $4.5 million since December 2017. Two days before the minority leader reportedly intervened in the surprise medical billing legislation, GNYHA members met with a Schumer aide in the senator's office in Washington.

As Stein and Abutaleb reported, the surprise billing legislation's collapse was just one in a series of wins by the healthcare industry in 2019, including victories on drug legislation, patents, and repealing parts of the Affordable Care Act that targeted the industry's bottom line.

"The success shows how formidable the health-care industry remains," wrote Stein and Abutaleb, "able to overwhelm Democrats with well-honed talking points and splinter Republicans through a concerted push."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

This is the world we live in. This is the world we cover.

Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do. Without Your Support We Simply Don't Exist.

Coalition Urges Biden to Make 'Transformative Change' in Approach to Global Food and Agriculture

"This pro-corporate agriculture agenda must change under your watch."

Andrea Germanos ·


Mondaire Jones Warns Against Watering Down Human Infrastructure Proposals

The New York Democrat is advocating universal programs, not means-tested ones, for programs in the Build Back Better plan.

Andrea Germanos ·


Manchin Threatening Key Climate Provision: Reports

"To take it out is to decide that climate change isn't a problem."

Andrea Germanos ·


'Make a Gesture of Humanity': Pope Francis Urges Pharma Giants to Release Covid-19 Vaccine Patents

"There are countries where only three or four percent of the inhabitants have been vaccinated."

Andrea Germanos ·


Manchin Fumes After Sanders Op-Ed in West Virginia Paper Calls Out Obstruction of Biden Agenda

"Poll after poll shows overwhelming support for this legislation," wrote Sanders. "Two Democratic senators remain in opposition, including Sen. Joe Manchin."

Andrea Germanos ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo